DEPDC1B, CDCA2, APOBEC3B, and TYMS are potential hub genes and therapeutic targets for diagnosing dialysis patients with heart failure.

Journal: Frontiers in cardiovascular medicine
Published Date: Jan 8, 2025

Abstract

INTRODUCTION: Heart failure (HF) has a very high prevalence in patients with maintenance hemodialysis (MHD). However, there is still a lack of effective and reliable HF diagnostic markers and therapeutic targets for patients with MHD.

Authors

  • Wenwu Tang
    Department of Nephrology, Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong, China.
  • Zhixin Wang
    Department of Nephrology, Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong, China.
  • Xinzhu Yuan
    Department of Nephrology, Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong, China.
  • Liping Chen
    Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Haiyang Guo
    College of Clinical Medicine, North Sichuan Medical College, Nanchong, China.
  • Zhirui Qi
    College of Clinical Medicine, North Sichuan Medical College, Nanchong, China.
  • Ying Zhang
    Department of Nephrology, Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong, China.
  • Xisheng Xie
    Department of Nephrology, Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals